Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.

Harbeck N, Rastogi P, Martin M, Tolaney SM, Shao ZM, Fasching PA, Huang CS, Jaliffe GG, Tryakin A, Goetz MP, Rugo HS, Senkus E, Testa L, Andersson M, Tamura K, Del Mastro L, Steger GG, Kreipe H, Hegg R, Sohn J, Guarneri V, Cortés J, Hamilton E, André V, Wei R, Barriga S, Sherwood S, Forrester T, Munoz M, Shahir A, San Antonio B, Nabinger SC, Toi M, Johnston SRD, O'Shaughnessy J, monarchE Committee Members

Open source

DOI: 10.1016/j.annonc.2021.09.015
Published: 2021 Dec
Container: Annals of oncology : official journal of the European Society for Medical Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2021.09.015,
  title = {Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.},
  author = {Harbeck N and Rastogi P and Martin M and Tolaney SM and Shao ZM and Fasching PA and Huang CS and Jaliffe GG and Tryakin A and Goetz MP and Rugo HS and Senkus E and Testa L and Andersson M and Tamura K and Del Mastro L and Steger GG and Kreipe H and Hegg R and Sohn J and Guarneri V and Cortés J and Hamilton E and André V and Wei R and Barriga S and Sherwood S and Forrester T and Munoz M and Shahir A and San Antonio B and Nabinger SC and Toi M and Johnston SRD and O'Shaughnessy J and monarchE Committee Members},
  year = {2021},
  journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
  doi = {10.1016/j.annonc.2021.09.015},
  url = {https://doi.org/10.1016/j.annonc.2021.09.015}
}

RIS

TY  - JOUR
TI  - Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
AU  - Harbeck N
AU  - Rastogi P
AU  - Martin M
AU  - Tolaney SM
AU  - Shao ZM
AU  - Fasching PA
AU  - Huang CS
AU  - Jaliffe GG
AU  - Tryakin A
AU  - Goetz MP
AU  - Rugo HS
AU  - Senkus E
AU  - Testa L
AU  - Andersson M
AU  - Tamura K
AU  - Del Mastro L
AU  - Steger GG
AU  - Kreipe H
AU  - Hegg R
AU  - Sohn J
AU  - Guarneri V
AU  - Cortés J
AU  - Hamilton E
AU  - André V
AU  - Wei R
AU  - Barriga S
AU  - Sherwood S
AU  - Forrester T
AU  - Munoz M
AU  - Shahir A
AU  - San Antonio B
AU  - Nabinger SC
AU  - Toi M
AU  - Johnston SRD
AU  - O'Shaughnessy J
AU  - monarchE Committee Members
PY  - 2021
JO  - Annals of oncology : official journal of the European Society for Medical Oncology
DO  - 10.1016/j.annonc.2021.09.015
UR  - https://doi.org/10.1016/j.annonc.2021.09.015
ER  -

APA

N, H., P, R., M, M., SM, T., ZM, S., PA, F., CS, H., GG, J., A, T., MP, G., HS, R., E, S., L, T., M, A., K, T., L, D. M., GG, S., H, K., R, H., J, S., V, G., J, C., E, H., V, A., R, W., S, B., S, S., T, F., M, M., A, S., B, S. A., SC, N., M, T., SRD, J., J, O., & Members, M. C. (2021). Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2021.09.015

Source records

pubmed · retrieved 2026-09-26T15:52:50.660Z